GlassScriptPhysician profile
Magdeley Mordan
NPI 1932757101
$1,186.15
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.42 · 2023: $119 · 2024: $1,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,165.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $255.89 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $233.15 | 2023-2024 | |
| Lilly USA, LLC | $102.09 | 2024 | Zepbound, Mounjaro |
| Amgen INC. | $90.25 | 2024 | Otezla, Repatha, Krystexxa |
| Astrazeneca Pharmaceuticals LP | $84.35 | 2024 | Airsupra, Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $53.67 | 2024 | |
| Shield Therapeutics INC | $53.50 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $53.06 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $52.22 | 2024 | Cologuard Collection Kit |
| Abbvie INC. | $34.34 | 2024 | |
| Nevro Corp. | $23.17 | 2024 | Senza |
| Scilex Pharmaceuticals INC. | $22.62 | 2023 | Ztlido |
| Sanofi-Aventis U.S. LLC | $20.50 | 2024 | |
| Merck Sharp & Dohme LLC | $20.42 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.52 | 2024 | Jardiance |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $19.44 | 2024 | (Ck7) Extended Holter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.81 | 2024 | Xifaxan |
| Dexcom, INC. | $16.74 | 2024 | Dexcom G6 Transmitter |
| Lucid Diagnostics INC. | $13.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Magdeley Mordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.